A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data

Author： Rioux Nathalie   Batonga Joëlle   Colombo Federico   Massé Jonathan   Zouki Christine   Ribadeneira Maria D.   Duan Jianmin   Bethell Richard C.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.43, Iss.7, 2013-07, pp. : 592-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP Inhibition-Mediated Drug-Drug Interactions

By  

Current Enzyme Inhibition, Vol. 6, Iss. 3, 2010-10 ,pp. : 130-145

Bentham Science Publishers

Access to resources Recommend Favorite

Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein

By Tachibana T.   Kato M.   Watanabe T.   Mitsui T.   Sugiyama Y.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 430-443

Informa Healthcare

Access to resources Recommend Favorite

Comparison of different approaches to predict metabolic drug–drug interactions

By Einolf H. J.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-06 ,pp. : 1257-1294

Informa Healthcare

Access to resources Recommend Favorite

Enzymatic characteristics of CYP3A5 and CYP3A4: A comparison of in vitro kinetic and drug–drug interaction patterns

By Emoto C.   Iwasaki K.  

Xenobiotica, Vol. 36, Iss. 2-3, 2006-02 ,pp. : 219-233

Informa Healthcare

Access to resources Recommend Favorite

Assessment of drug-drug interactions: concepts and approaches

By Weaver R. J.  

Xenobiotica, Vol. 31, Iss. 8-9, 2001-08 ,pp. : 499-538

Informa Healthcare

Access to resources Recommend Favorite